Vitamin K2

Vitamin K2, also known as menaquinone, is essential for bone and cardiovascular health. It activates proteins that regulate calcium distribution, ensuring its storage in bones and teeth and preventing its accumulation in arteries, which reduces the risk of vascular calcification.

Dr. Leon Schurgers, a leading researcher in this field, has shown that vitamin K2 plays a crucial role in preventing cardiovascular disease and osteoporosis.

Additionally, studies suggest that K2 may contribute to dental and brain health and has anti-inflammatory properties. It's found in fermented foods and animal products, and is also available in supplement form.

Vitamin K2 is difficult to obtain in sufficient quantities through the modern diet, since its main sources, such as fermented foods and certain meats, are not commonly consumed in many regions.

K2 supplementation ensures optimal support for activating key proteins such as osteocalcin and MGP, which are essential for directing calcium toward the bones and preventing its accumulation in the arteries.

Taking it as a supplement is a safe and effective way to maximize its benefits, especially when combined with vitamin D3 for a synergistic effect in the body.

The effectiveness of this product, designed by our Scientific Committee, is constantly measured by extensive diagnostic and analytical testing in the most prestigious Age Management clinics.

0 – 1 - 0

​

Each package contains 90 capsules of 400 mg/unit, perfect to cover your needs for three months.

It is recommended to take 1 capsule a day with food.

Vitamin K2 is fat-soluble. This means it dissolves in fats and oils and is best absorbed when consumed alongside foods containing healthy fats. Its fat-soluble nature also allows it to be stored in the body's fatty tissue, providing a reserve that can be used over time.

• When will I notice the benefits?In 2-4 weeks:
• Improved blood clotting (if there was a prior deficiency): Regulation of healing processes may be observed. Initial cardiovascular support: Begins to reduce calcium buildup in the arteries, although significant effects are cumulative.In 1-3 months:
• Increased bone density: Improves bone mineralization by activating osteocalcin, reducing fragility in people at risk. More evident cardiovascular support: Progressive reduction in the risk of arterial calcification, especially when combined with vitamin D3.In + 3-6 months:

Sustained bone and cardiovascular health: Maintains strong bones and significantly reduces the risk of cardiovascular disease. Chronic disease prevention: Slows the progression of problems related to vascular and bone calcification.

• Maltodextrin
• : Thickener that stabilizes the formula.Vitamin K2 (menaquinone) 90 µg (120% NRV*)
• : Essential for bone and cardiovascular health.Anti-caking agent

2. Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C. "Vitamin K–containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7." Blood. 2007;109(8):3279-3283.​
3. Gast GC, de Roos NM, Sluijs I, et al. "A high menaquinone intake reduces the incidence of coronary heart disease." Nutrition, Metabolism and Cardiovascular Diseases. 2009;19(7):504-510.​
4. Beulens JW, Bots ML, Atsma F, et al. "High dietary menaquinone intake is associated with reduced coronary calcification." Atherosclerosis. 2009;203(2):489-493​
5. Knapen MH, Drummen NE, Smit E, et al. "Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women." Osteoporosis International. 2013;24(9):2499-2507.​
6. Geleijnse JM, Vermeer C, Grobbee DE, et al. "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study." Journal of Nutrition. 2004;134(11):3100-3105.
7. Schurgers LJ, Spronk HM, Soute BA, et al. "Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats." Blood. 2007;109(7):2823-2831. ​
8. Kurnatowska I, Grzelczyk A, Kaczmarski M, et al. "Effect of vitamin K2 supplementation on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5." Polish Archives of Internal Medicine. 2015;125(9):631-640.​
9. Theuwissen E, Magdeleyns EJ, Braam LA, et al. "Vitamin K status in healthy volunteers." Food & Function. 2014;5(2):229-234.​
10. Beulens JW, van der A DL, Grobbee DE, et al. "Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes." Diabetes Care. 2010;33(8):1699-1705.​